Stay updated on SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.

Latest updates to the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page
- Check2 days agoChange DetectedAdded a Publications section with a PubMed citation for a 2025 paper and a note that PubMed data auto-populates. Updated the revision entry to v3.6.4, replacing v3.6.3.SummaryDifference0.3%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe revision number on the page was updated from v3.6.2 to v3.6.3, representing a software update to the page's rendering or maintenance without altering the study content.SummaryDifference0.0%

- Check30 days agoChange DetectedThe page's revision tag was updated from v3.6.0 to v3.6.2, indicating a page update. This reflects versioning just for the page and does not alter the study data or documented requirements.SummaryDifference0.0%

- Check45 days agoChange DetectedThe page adds new navigation/help items (No longer looking for participants, How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting, while replacing the Revision note from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check52 days agoChange DetectedRevision updated from v3.5.4 to v3.5.5 on the page, indicating a minor UI/content rendering update.SummaryDifference0.0%

- Check73 days agoChange DetectedRevision: v3.5.4 updated from v3.5.3 on the page. This change reflects a backend/content version bump rather than alterations to the study details or public-facing information.SummaryDifference0.0%

Stay in the know with updates to SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SNDX-6352 & Durvalumab in Solid Tumors Clinical Trial page.